NCT01828112 2025-02-07LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and CrizotinibNovartisPhase 3 Completed231 enrolled 33 charts
NCT01828099 2025-01-16LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung CancerNovartisPhase 3 Completed376 enrolled 34 charts 2 FDA
NCT01041781 2018-07-23Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerAlliance for Clinical Trials in OncologyPhase 3 Terminated313 enrolled 14 charts
NCT00863512 2017-03-27Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerAlliance for Clinical Trials in OncologyPhase 3 Terminated34 enrolled 6 charts